DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M. et al.
Trastuzumab emtansine for residual invasive HER2-positive breast cancer.
N Engl J Med 2019;
380: 617-28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.